Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Non-Randomized Study to Evaluate Anti-Malarial/Anti-Infective Combination Therapies in Patients With Confirmed COVID-19 Infection

NCT04339426 is registered in ClinicalTrials.gov with HonorHealth Research Institute as lead sponsor.

NCT NCT04339426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04339426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Non-Randomized Study to Evaluate Anti-Malarial/Anti-Infective Combination Therapies in Patients With Confirmed COVID-19 Infection
Lead sponsor
HonorHealth Research Institute
Phase
Phase 2
Overall status
Terminated
Start date
April 20, 2020
Completion date
February 11, 2022
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19